MXN tablets

Dexa Medica

Ingredients in every tablet

Moxifloxacin 400 mg

Each package contains

1 strip of 10 tablets

Other details

Dosage form:Tablet; coated
Flavour None

W.H.O. classification

ATC Level 1 J - Antiinfectives for systemic use
ATC Level 2 J01 - Antibacterials for Systemic Use
ATC Level 3 J01M - Quinolone Antibacterials

Warnings

Pregnancy

NOT SAFEThis item is not safe for use during pregnancy.

Lactation

NOT SAFEThis item is not safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Available in

Indonesia

Dosage information

18 YEARS OLD AND ABOVE
The recommended dose for moxifloxacin is one 400 mg tablet once daily. No adjustment of dosage is required in elderly patients.

For treatment of skin and soft tissue infections requiring initial intravenous therapy followed by administration of 400 mg moxifloxacin tablet.

The film-coated tablets should be swallowed whole with sufficient liquid and may be taken independent of meals.

Duration of treatment
Moxifloxacin tablet should be used for the following treatment durations:
- Acute exacerbation of chronic bronchitis for 5-10 days.
- Community-acquired pneumonia for 10 days.
- Acute sinusitis for 7 days.
- Complicated skin and soft tissue for 7-21 days.
The recommended dose (400 mg once daily) and duration of therapy for the indication being treated should not be exceeded

0 TO 18 YEARS OLD
Efficacy and safety have not been established.

The film-coated tablets should be swallowed whole with sufficient liquid and may be taken independent of meals.

Duration of treatment
Moxifloxacin tablet should be used for the following treatment durations:
- Acute exacerbation of chronic bronchitis for 5-10 days.
- Community-acquired pneumonia for 10 days.
- Acute sinusitis for 7 days.
- Complicated skin and soft tissue for 7-21 days.
The recommended dose (400 mg once daily) and duration of therapy for the indication being treated should not be exceeded

IMPAIRED LIVER FUNCTION
No dosage adjustment is required in patients with impaired liver function (creatinine clearance ≤30 ml/minute/1.73m²).

Indication

Moxifloxacin is indicated for the treatment in Adults (> 18 years of age) for the following bacterial infections:
a. Upper respiratory tract infections
– Acute exacerbations of chronic bronchitis.
– Community-acquired pneumonia
– Acute sinusitis.

b. Skin and soft tissue infections
Moxifloxacin is indicated for the treatment of the infections caused by bacteria susceptible to moxifloxacin.